GPD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.38129999958248E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.21689999999608E-05 |
Normal-vs-Stage2 |
1.061620E-03 |
Normal-vs-Stage3 |
3.17449999620578E-08 |
Normal-vs-Stage4 |
2.97549999972446E-07 |
Stage1-vs-Stage2 |
8.902600E-01 |
Stage1-vs-Stage3 |
3.777500E-03 |
Stage1-vs-Stage4 |
4.126200E-02 |
Stage2-vs-Stage3 |
7.019500E-02 |
Stage2-vs-Stage4 |
1.361020E-01 |
Stage3-vs-Stage4 |
6.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.19269999998561E-06 |
Normal-vs-AfricanAmerican |
5.05940000006255E-07 |
Normal-vs-Asian |
1.902160E-02 |
Caucasian-vs-AfricanAmerican |
1.892210E-01 |
Caucasian-vs-Asian |
6.549600E-01 |
AfricanAmerican-vs-Asian |
3.178600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.03539999977087E-07 |
Normal-vs-Female |
4.70409999997479E-06 |
Male-vs-Female |
4.846600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.582400E-03 |
Normal-vs-Age(41-60Yrs) |
3.45260000000902E-06 |
Normal-vs-Age(61-80Yrs) |
1.03969999998288E-06 |
Normal-vs-Age(81-100Yrs) |
3.05130000000098E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.644600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.895400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.661600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.251000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.740450E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.806410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.281620E-02 |
Normal-vs-Grade 2 |
1.434140E-04 |
Normal-vs-Grade 3 |
8.24720000069945E-08 |
Normal-vs-Grade 4 |
3.23619997466551E-09 |
Grade 1-vs-Grade 2 |
9.341800E-01 |
Grade 1-vs-Grade 3 |
1.479640E-01 |
Grade 1-vs-Grade 4 |
3.509500E-02 |
Grade 2-vs-Grade 3 |
1.002540E-03 |
Grade 2-vs-Grade 4 |
1.434140E-04 |
Grade 3-vs-Grade 4 |
4.510300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.221500E-04 |
Normal-vs-ccB subtype |
5.22090000010245E-07 |
ccA subtype-vs-ccB subtype |
9.696300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.70259999998645E-06 |
Normal-vs-N1 |
2.205800E-02 |
N0-vs-N1 |
9.996000E-01 |
|
|